Texas Tech University Health Sciences Center El Paso President Richard Lange, M.D., M.B.A., has been appointed as panel chair for the U.S. Food and Drug Administration Circulatory Systems Devices Panel.
“I look forward to working with the FDA to accomplish those goals, to bring these devices to the public earlier and as quickly as possible, while still ensuring their safety,” Dr. Lange said.
Dr. Lange, who is also dean of the Paul L. Foster School of Medicine at TTUHSC El Paso, is a practicing cardiologist and has served on the FDA Circulatory Systems Devices Panel since 2010.
His term as chair will last four years, at a time when the FDA is going through important changes, including efforts to move drugs and devices through the approval process faster, especially for breakthrough drugs and devices.
The panel reviews and evaluates data about the safety and effectiveness of marketed and investigational medical devices for use in the circulatory and vascular systems.
They then make appropriate recommendations to the FDA commissioner.